EventsThe 4th International Online Conference on Nanomaterials
Published
with-doi10.3390/IOCN2023-14499 (registering DOI)
This submission belongs to the session F. Nanomedicine and Nanobiotechnology of the event The 4th International Online Conference on Nanomaterials
Published date
05 May, 2023
Academic Editor
author-avatarAurélien Deniaud
Citation
Anatolii Abalymov, Sergei German, Maxim Kurochkin, Marina Novoselova, Yuliya Kan, Plug-and-Play Lymph Node-on-Chip: Possibility of Passage of Polymer Capsules to Secondary Tumor, Designed By Combination Of Cell Spheroid, Collagen Sponge and T-cells, in Proceedings of The 4th International Online Conference on Nanomaterials, 5 May–19 May 2023, MDPI: Basel, Switzerland, doi: 10.3390/IOCN2023-14499
Share
Email
Facebook
Twitter
LinkedIn

Plug-and-Play Lymph Node-on-Chip: Possibility of Passage of Polymer Capsules to Secondary Tumor, Designed By Combination Of Cell Spheroid, Collagen Sponge and T-cells

image
Marina Novoselova 2
1. Science Medical Center, Saratov State University, Saratov 410012, Russia, Belgium
2. Skolkovo Institute of Science and Technologies, Moscow 121205, Russia
Abstract

Towards the improvement of the efficient study of drugs and contrast agents, the 3D microfluidic platforms are currently being actively developed for testing these substances and particles in vitro. Such bioengineering solutions, can bring the system much closer to real-world conditions without the unnecessary use of laboratory animals. Also, the application of engineering methods allows the fine-tuning of the resulting structures for their installation and long-term observation in imaging systems. We have elaborated a microfluidic lymph node-on-chip (LNOC) as a tissue engineered model of a secondary tumor in lymph node (LN) formed due to the metastasis process. The developed chip has a collagen sponge with a 3D spheroid of 4T1 cells located inside, simulating secondary tumor in the lymphoid tissue. This collagen sponge has a morphology and porosity comparable to that of a native human LN. To demonstrate the suitability of the obtained chip for pharmacological appli-cations, we used it to evaluate the effect of contrast agent/drug carrier size, on the penetration and accumulation of particles in 3D spheroids modeling secondary tumor. For this, the 0.3, 0.5 and 4 μm bovine serum albumin (BSA)/tannic acid (TA) capsules were mixed with lymphocytes and pumped through the developed chip.
Thus, in our study, 0.3 μm capsules, which penetrated well into the spheroid, turned out to be the most effective for delivery. These results highlight the potential of our LNOC for use in particle and contrast agent testing. They also demonstrate that the LNOC is an attractive alternative for further analysis and understanding of the effectiveness of developed drug delivery vehicles and contrast agents delivered to cells and organs. Moreover, some findings that we have obtained during the development of our device can be used for the elab-oration of other types of lab-on-chip systems.

Keywords
Organ-On-Chip
Polymer Capsules
Spheroids
Manuscript
Synthesis and characterization of a bifunctional platform based on magnetite-gold nanoparticles for theranostics of cancer
Study of photoresistor fabrication based on mercury chalcogenides applying various ligand exchanges